168 related articles for article (PubMed ID: 25416410)
1. Urinary protein biomarkers in the early detection of lung cancer.
Nolen BM; Lomakin A; Marrangoni A; Velikokhatnaya L; Prosser D; Lokshin AE
Cancer Prev Res (Phila); 2015 Feb; 8(2):111-9. PubMed ID: 25416410
[TBL] [Abstract][Full Text] [Related]
2. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
3. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
4. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
5. Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.
Takahashi Y; Horio H; Sakaguchi K; Hiramatsu K; Kawakita M
BMC Cancer; 2015 Feb; 15():65. PubMed ID: 25884987
[TBL] [Abstract][Full Text] [Related]
6. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
7. Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancer.
Ma YC; Tian PF; Chen ZP; Yue DS; Liu CC; Li CG; Chen C; Zhang H; Liu HL; Zhang ZF; Chen L; Zhang B; Wang CL
Cancer Sci; 2021 Jun; 112(6):2349-2360. PubMed ID: 33565687
[TBL] [Abstract][Full Text] [Related]
8. Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.
Takahashi Y; Sakaguchi K; Horio H; Hiramatsu K; Moriya S; Takahashi K; Kawakita M
Br J Cancer; 2015 Nov; 113(10):1493-501. PubMed ID: 26505680
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.
Mazzone PJ; Wang XF; Lim S; Choi H; Jett J; Vachani A; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
BMC Cancer; 2015 Dec; 15():1001. PubMed ID: 26698840
[TBL] [Abstract][Full Text] [Related]
10. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
Chen P; Lu W; Chen T
J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
[TBL] [Abstract][Full Text] [Related]
11. A multi-analyte serum test for the detection of non-small cell lung cancer.
Farlow EC; Vercillo MS; Coon JS; Basu S; Kim AW; Faber LP; Warren WH; Bonomi P; Liptay MJ; Borgia JA
Br J Cancer; 2010 Oct; 103(8):1221-8. PubMed ID: 20859284
[TBL] [Abstract][Full Text] [Related]
12. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.
Liu YZ; Jiang YY; Wang BS; Hao JJ; Shang L; Zhang TT; Cao J; Xu X; Zhan QM; Wang MR
Cancer Cytopathol; 2014 Nov; 122(11):833-41. PubMed ID: 25045014
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
[TBL] [Abstract][Full Text] [Related]
14. GM2-activator protein: a new biomarker for lung cancer.
Potprommanee L; Ma HT; Shank L; Juan YH; Liao WY; Chen ST; Yu CJ
J Thorac Oncol; 2015 Jan; 10(1):102-9. PubMed ID: 25490003
[TBL] [Abstract][Full Text] [Related]
15. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
[TBL] [Abstract][Full Text] [Related]
16. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of differentially expressed proteome in urine
from non-small cell lung cancer patients].
Chen Z; Liu J; Lin L; Xie H; Zhang W; Zhang H; Wang G
Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):138-45. PubMed ID: 25800569
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of urinary pseudouridine as a tumor marker in lung cancer.
Lu JY; Lai RS; Liang LL; Wang HC; Lin TI
J Formos Med Assoc; 1994 Jan; 93(1):25-9. PubMed ID: 7915576
[TBL] [Abstract][Full Text] [Related]
19. Detection of lung cancer in silicosis patients using a tumor-marker panel.
Schneider J
Cancer Biomark; 2010; 6(3-4):137-48. PubMed ID: 20660960
[TBL] [Abstract][Full Text] [Related]
20. A new biomarker panel in bronchoalveolar lavage for an improved lung cancer diagnosis.
Uribarri M; Hormaeche I; Zalacain R; Lopez-Vivanco G; Martinez A; Nagore D; Ruiz-Argüello MB
J Thorac Oncol; 2014 Oct; 9(10):1504-12. PubMed ID: 25105437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
